Company news
Coherus Oncology, Inc. news in 2020
Coherus Oncology, Inc.'s news releases, calls and decks from 2020, newest first.
Coherus BioSciences Reports Third Quarter 2020 Financial Results
November 4, 2020
Coherus BioSciences to Report Third Quarter Financial Results on November 5th
October 21, 2020
Coherus BioSciences Reports Second Quarter 2020 Financial Results
August 5, 2020
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
August 2, 2020
Coherus BioSciences to Report Second Quarter Financial Results on August 6th
July 15, 2020
Coherus BioSciences Reports First Quarter 2020 Financial Results
May 6, 2020
Coherus BioSciences to Report First Quarter Financial Results on May 7th
April 21, 2020
Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering
April 14, 2020
Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering
April 13, 2020
Coherus BioSciences Provides First Quarter 2020 Financial Update and Fiscal Year 2020 COVID-19 Impact Insights
April 12, 2020
Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results
February 26, 2020
Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States
January 12, 2020